Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-09-07

Clinical Trial Update: Clofarabine Pre-conditioning With Allogeneic Transplant for Acute Myeloid Leukaemia (AML) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on clofarabine pre-conditioning with allogeneic transplant for acute myeloid leukemia and myelodysplasia (Phase 1/Phase 2) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clofarabine (clofarabine)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Acute Myeloid Leukaemia, Myelodysplasia | Phase 1, Phase 2 | Status: COMPLETED